Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

AGA patients have lower serum vaspin levels, which might help detect the condition early.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

Androgenetic alopecia is common, affects self-image, and has no complete cure yet.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Removing anthrax toxin receptor 1 in pigs prevents Senecavirus A infection and causes a rare disease similar to GAPO syndrome.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

Polygonum multiflorum, especially emodin, may help treat hair loss by targeting specific proteins, offering a new approach beyond traditional therapies.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

N-acetyl-GED may help prevent and partially reverse a process that leads to scarring hair loss.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

Peripheral blood alive cell treatment is effective and safe for treating hair loss.

The new PRP treatment significantly improves hair growth.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

A new mutation in the AGPAT2 gene causes severe fat tissue loss and related health issues by reducing the protein's levels.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

The 2940-nm Er: YAG fractional laser may help treat receding frontal hairlines in men with androgenetic alopecia.

A woman with acromegaly experienced severe hair loss from a drug called Lanreotide Autogel, which improved after stopping the treatment.

AA–TF#15 significantly promotes hair regrowth and could be an effective treatment for androgenic alopecia.

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

New model shows muscle affects hair loss differently in men and women.

Androgenetic alopecia causes hair loss, affects men more severely, and treatments are only temporarily effective.

PRP improves hair thickness for both genders, but only increases hair density in men.

PRP combined with minoxidil may help treat hair loss, but better methods and standardized practices are needed.

The combination of minoxidil, microneedling, and PRP is more effective for hair growth than minoxidil alone.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.